Effect of thioridazine on gap junction intercellular communication in connexin 43-expressing cells

Cell Biology and Toxicology

Volumn 22, Issue 4, 2006, Pages 257-268

  Matesic, D F ^a   Abifadel, D N ^a   Garcia, E L ^a   Jann, M W ^a  

^a MERCER UNIVERSITY   (United States)

Author keywords

Connexin 43; Gap junction; Myocytes; Thioridazine

Indexed keywords

CONNEXIN 43; FLUORESCENT DYE; MESORIDAZINE; PHORBOL 13 ACETATE 12 MYRISTATE; THIORIDAZINE;

ANIMAL CELL; ARTICLE; CELL COMMUNICATION; CELL ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; GAP JUNCTION; HEART MUSCLE CELL; MICROINJECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; WESTERN BLOTTING;

ANIMALS; ANTIPSYCHOTIC AGENTS; CELL COMMUNICATION; CELL LINE; CONNEXIN 43; CONNEXINS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; FLUORESCENT DYES; GAP JUNCTIONS; KINETICS; PHOSPHORYLATION; RATS; THIORIDAZINE;

EID: 33745930246     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10565-006-0047-7     Document Type: Article

References (27)

1. Beyer E, Paul DL, Goodenough DA. Connexin43: a protein from rat heart homologous to a gap junction protein from liver. J Cell Biol. 1987;105:2621-9.
2. Britz-Cunningham SH, Shah MN, Zuppan CW, Fletcher WH. Mutations of the connexin43 gap-junction gene in patients with heart malformations and detects of laterality. N Engl J Med. 1995;332:1323-9.
3. Buckley NA, Whyte IM, Dawson AH. Cardiotoxicity more common in thioridazine overdose than with other neuroleptics. J Toxicol Clin Toxicol. 1995;33:199-204.
4. Budunova IV, Williams GM, Spray DC. Effect of tumor promoting stimuli on gap junction permeability and connexin43 expression in ARL 18 rat liver cell line. Arch Toxicol. 1993;67:565-72.
5. Dallaire S. Thioridazine (Mellaril) and mesoridazine (Serentil): prolongation of the QTc interval. Can Med Assoc J. 2001;164:91.
6. Dhein S. Gap junction channels in the cardiovascular system: pharmacological and physiological modulation. Trends Pharmacol Sci. 1998;19:229-41.
7. Gros DB, Jongsma HJ. Connexins in mammalian heart function. BioEssays. 1996;18:719-30.
8. Hale PW Jr, Poklis A. Thioridazine-5-sulfoxide cardiotoxicity in the isolated perfused rat heart. Toxicol Lett. 1984;21:1-8.
9. Hale PW Jr, Poklis A. Cardiotoxicity of thioridazine and two stereoisomeric forms of thioridazine 5-sulfoxide in the isolated perfused rat heart. Toxicol Appl Pharmacol. 1986;86:44-55.
10. Hale PW Jr, Poklis A. Thioridazine cardiotoxicity. J Toxicol Clin Toxicol. 1996;34:127-30.
11. Huston JR, Bell GE. The effect of thioridazine hydrochloride and chlorpromazine on the electrocardiogram. JAMA. 1966;198:134-38.
12. Kelly HQ, Fay JE, Laverty FG. Thioridazine hydrochloride (Mellaril): its effect on the electrocardiogram and a report on two fatalities. Can Med Assoc J. 1963;89:546-54.
13. Laird DW, Revel JP. Biochemical and immunochemical analysis of the arrangement of connexin43 in rat heart gap junction membranes. J Cell Sci. 1990;97(Pt 1):109-17.
14. Lampe PD, TenBroek EM, Burt JM, Kurata WE, Johnson RG, Lau AF. Phosphorylation of connexin43 on serine368 by protein kinase C regulates gap junctional communication. J Cell Biol. 2000;149:1503-12.
15. Manjunath CK, Goings GE, Page E. Cytoplasmic surface and intramembrane components of rat heart gap junctional proteins. Am J Physiol. 1984;246:H865-75.
16. Martensson E, Nyberg G, Axelsson R. Quantitative determination of thioridazine and nonconjugated thioridazine metabolites in serum and urine of psychiatric patients. Curr Ther Res. 1975;18:687-700.
17. Matesic DF, Rupp HL, Bonney WJ, Ruch RJ, Trosko JE. Changes in gap-junction permeability, phosphorylation, and number mediated by phorbol ester and non-phorbol-ester tumor promoters in rat liver epithelial cells. Mol Carcinog. 1994;10:226-36.
18. Musil LS, Goodenough DA. Biochemical analysis of connexin43 intracellular transport, phosphorylation, and assembly into gap junctional plaques. J Cell Biol. 1991;115:1357-74.
19. Page E. Cardiac gap junctions. In: Fozzard HS et al., eds. The heart and cardiovascular system. New York: Raven Press; 1992:1003-48.
20. Reaume AG, de Sousa PA, Kulkarni S, et al. Cardiac malformation in neonatal mice lacking connexin43. Science. 1995;267:1831-34.
21. Rohr S. Role of gap junctions in the propagation of the cardiac action potential. Cardiovasc Res. 2004;62:309-22.
22. Severs NJ. Cardiac muscle cell interaction: from microanatomy to the molecular make-up of the gap junction. Histol Histopathol. 1995;10:481-501.
23. Trosko JE, Chang CC, Madhukar BV. In vitro analysis of modulators of intercellular communication: implications for biologically based risk assessment models for chemical exposure. Toxicol In Vitro. 1990;4:635-43.
24. Tsao MS, Smith JD, Nelson KG, Grisham JW. A diploid epithelial cell line from normal adult rat liver with phenotypic properties of "oval" cells. Exp Cell Res. 1984;154:38-52.
25. Von Bahr C, Movin G, Nordin C, et al. Plasma levels of thioridazine and metabolites are influenced by the debrisoquin hydroxylation phenotype. Clin Pharmacol Ther. 1991;49:234-240.
26. Vozzi C, Dupont E, Coppen SR, Yeh HI, Severs NJ. Chamber-related differences in connexin expression in the human heart. J Mol Cell Cardiol. 1999;31:991-1003.
27. Willecke K, Elberger J, Degen J, et al. Structural and functional diversity of connexin genes in the mouse and human genome. Biol Chem. 2002;383:25-37.